A. SARI Et Al. , "Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis," American College of Rheumatology, ACR Convergence-2017 , United States Of America, 2017
SARI, A. Et Al. 2017. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis. American College of Rheumatology, ACR Convergence-2017 , (United States Of America).
SARI, A., ARMAĞAN, B., ERDEN, A., KILIÇ, L., KARADAĞ, Ö., AKDOĞAN, A., ... KALYONCU, U.(2017). Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis . American College of Rheumatology, ACR Convergence-2017, United States Of America
SARI, ALPER Et Al. "Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis," American College of Rheumatology, ACR Convergence-2017, United States Of America, 2017
SARI, ALPER Et Al. "Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis." American College of Rheumatology, ACR Convergence-2017 , United States Of America, 2017
SARI, A. Et Al. (2017) . "Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis." American College of Rheumatology, ACR Convergence-2017 , United States Of America.
@conferencepaper{conferencepaper, author={ALPER SARI Et Al. }, title={Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis}, congress name={American College of Rheumatology, ACR Convergence-2017}, city={}, country={United States Of America}, year={2017}}